Ankle Devices for Sarcopenia

Phase < 1

Recruiting

Research Sponsored by Northern Arizona University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age between 65 and 85 years old, inclusive

Able to walk at least 30 feet with or without a walking aid

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 day

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to help older people move better by testing if wearing special devices on their ankles can improve their walking ability. They will also see if using these devices on the ankle, knee, or hip

Who is the study for?

This trial is for older adults with sarcopenia, which means they've lost muscle mass and strength. Participants should be interested in improving their walking ability. Specific eligibility details are not provided, so generally healthy older adults looking to enhance mobility may apply.

What is being tested?

The study is testing two approaches: one where participants walk with added resistance at the ankle to strengthen muscles, and another where they use wearable devices that assist movement at the ankle, knee, or hip to improve walking.

What are the potential side effects?

Since this trial involves physical training and wearable devices for assistance, potential side effects might include muscle soreness or fatigue from resistance exercises and discomfort or skin irritation from wearing the devices.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 65 and 85 years old.

Select...

I can walk at least 30 feet by myself or with help.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 day

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 day

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

6MWT

Metabolic power

Plantar flexor strength

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Gait training with exoskeleton resistanceExperimental Treatment1 Intervention

Participants will complete 20-30 minutes of ankle resistance training on each visit. This will involve walking on a treadmill with stance phase ankle resistance and biofeedback.

0 / 2Eligibility criteria met